Coronary Arteriosclerosis: Clinical Trials

9 trials for Coronary Arteriosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 not yet recruiting, 1 unknown. 9 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 7, Not yet recruiting 1, Unknown 1
Phase 31Completed 1

Follow Coronary Arteriosclerosis: new trials by email Literature Review of Coronary Arteriosclerosis trials Research Report on Coronary Arteriosclerosis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) - low dose, Human Recombinant Fibroblast Growth Factor-1 (FGF1-141) - high dose, Placebo - Coronary Disease, Coronary Heart Disease
Phase 2Not yet recruitingVenturis Therapeutics, Inc.1502027-09-012026-08-19
Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery
Aspirin - Coronary Arteriosclerosis
Phase 2UnknownCentro Cardiologico Monzino992011-09-012011-11-08
Plug Arterial Closure System (PACS, 7F)
Vascular access site closure (7F Ensure) - Angioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis
Phase 2CompletedCordis US Corp.302007-07-012012-02-28
Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event
prasugrel 10 mg, clopidogrel, prasugrel placebo - Coronary Arteriosclerosis, Acute Coronary Syndrome
Phase 2CompletedEli Lilly and Company1392006-07-012010-11-03
Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery
TP10 - Myocardial Ischemia, Coronary Arteriosclerosis
Phase 2CompletedAvant Immunotherapeutics3002004-04-012007-07-20
Estrogen, HDL, and Coronary Heart Disease in Women
Estrogens, Conjugated (USP), Medroxyprogesterone 17-Acetate, Placebo - Cardiovascular Diseases, Coronary Disease
Phase 2 / Phase 3CompletedTufts University3092004-03-012016-04-21
Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease
Forearm blood flow study, Brachial artery reactivity study, Treadmill exercise test - Coronary Arteriosclerosis
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)422003-09-252017-07-02
Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
dietary supplements, vitamin C, vitamin E - Cardiovascular Diseases, Coronary Arteriosclerosis
Phase 2CompletedBrigham and Women's Hospital1993-05-012020-07-15
Lifestyle Heart Trial
diet, vegetarianism, diet, fat-restricted, exercise - Cardiovascular Diseases, Coronary Arteriosclerosis
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)1989-04-012013-12-13

Narrower conditions

Coronary Artery Disease (9)  ·  Coronary Disease (4)  ·  Myocardial Ischemia (4)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Acute Coronary Syndrome (1)  ·  Aneurysm (1)  ·  Aortic Valve Insufficiency (1)  ·  Atherosclerosis (1)  ·  Hypercholesterolemia (1)  ·  Hypertension (1)  ·  Ischemia (1)  ·  Mitral Valve Insufficiency (1)  ·  Motor Activity (1)  ·  Myocardial Infarction (1)

Broader conditions

Arterial Occlusive Diseases (9)  ·  Arteriosclerosis (9)  ·  Vascular Diseases (9)  ·  Cardiovascular Diseases (6)  ·  Heart Diseases (6)  ·  Coronary Disease (5)  ·  Myocardial Ischemia (5)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Aortic Valve Disease (1)  ·  Behavior (1)  ·  Dyslipidemias (1)  ·  Heart Valve Diseases (1)  ·  Hyperlipidemias (1)  ·  Infarction (1)

Interventions

Ascorbic Acid (1)  ·  Aspirin (1)  ·  Clopidogrel (1)  ·  Diet (1)  ·  Diet, Fat-Restricted (1)  ·  Diet, Vegetarian (1)  ·  Dietary Supplements (1)  ·  Estrogens, Conjugated (USP) (1)  ·  Exercise (1)  ·  Medroxyprogesterone Acetate (1)  ·  Prasugrel Hydrochloride (1)  ·  Sugars (1)  ·  Vitamin E (1)  ·  beta Carotene (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  Avant Immunotherapeutics (1)  ·  Brigham and Women's Hospital (1)  ·  Centro Cardiologico Monzino (1)  ·  Cordis US Corp. (1)  ·  Eli Lilly and Company (1)  ·  Tufts University (1)  ·  Venturis Therapeutics, Inc. (1)

Countries

United States (4)  ·  Italy (1)  ·  Mexico (1)

Top investigators

David M Herrington, MD (1)  ·  Dean Ornish (1)  ·  Emerson Perin, MD, PhD (1)  ·  JoAnn Manson (1)  ·  Jorge Luna, MD (1)  ·  K. Gould (1)  ·  Stefania Lamon-Fava (1)

Results publications

PMID 17698683, PMID 18174456, PMID 18460663, PMID 18984888, PMID 19064521, PMID 19116389, PMID 19155011, PMID 19237716, PMID 19451353, PMID 19489872, PMID 19491213, PMID 19491386, PMID 20580029, PMID 20846599, PMID 23066166, PMID 23223867, PMID 29776960, PMID 34039021

NIH funding

R01HL042554 (1), R01HL046959 (1), R01HL070081 (1)